Skip to content
Menu

Freedom Capital Markets Maintains Hold on AtriCure, Maintains $57 Price Target

Benzinga Newsdesk 7 hours ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Freedom Capital Markets analyst Keith Hinton maintains AtriCure (NASDAQ:ATRC) with a Hold and maintains $57 price target.

Freedom Capital Markets analyst Keith Hinton maintains AtriCure (NASDAQ:ATRC) with a Hold and maintains $57 price target.

Read at benzinga.com